The AstraZeneca development comprises a total of 59,821sqm (gross external area excluding plant) of biotech and biomedical research and development floorspace, to include: i) R&D centre and corporate headquarters, ii) R&D enabling building, iii) support building and energy centre, iv) associated car, motorbike and cycle parking, v) hard and soft landscaping, vi) internal roads, supporting facilities and ancillary infrastructure.
AstraZeneca’s vision is that their scheme will be an innovative response to the context of their site at the heart of the Campus. By relocating to the Campus, AstraZeneca is making a strong commitment to Cambridge to join with partnership research institutes, hospitals and the university to build a world-respected science and research cluster with unparalleled opportunities for collaborative research.
Architecturally, AstraZeneca seeks that its new home blends organically with the local environment whilst providing exciting architecture that reflects its collaborative and open vision.
Operationally, the new building will be porous to the surrounding campus, enabling movement and facilitating interactions with local educational and healthcare institutions, R&D companies and the local community. The architecture of the buildings and layout of the site are to reflect this aspiration for permeability and openness.